DrugBank总结

DrugBank是一个药物数据库,最近复现论文的时候总是用到这个数据库,但都是github上作者处理好的数据,我一直想看看drugbank长得啥样,就从官网上拿到了DrugBank数据集来看看

获取:drugbank是一个开源数据集,可以在官网上下载,但是是需要获得别人的许可的,要给人家发邮件,得到许可之后就可以下载啦,过程挺漫长的。。。其实也就来回几封邮件的事,但是人家在加拿大,每次回我邮件都是凌晨,2点3点5点。。。而我回人家的时候就下班了。。。然后还有周末人家可能不上班,来来回回四五天才拿到。

格式:xml格式

DrugBank总结_第1张图片

1G多,drugbank是根目录,一级子目录下面包含了很多drug,每个drug有很多属性

比如drugbank-id primary 这个就是他的ID,这个在很多代码里看到过,应该是他们处理好了以后的。

这里我把第一个drugbank的数据拿出来就都明白了。

另外,处理这个数据的一篇比较好的论文代码:

https://github.com/tticoin/DESC_MOL-DDIE/tree/master/databaseb

看看人家的readme部分,如果shell脚本看不懂的话也没关系,直接去读get_dict.py代码应该也能懂的,快速了解drugbank的方式

drugbank太大了,不方便调试,建议取出一个drug来测试(下面的代码)



  DB00001
  BTD00024
  BIOD00024
  Lepirudin
  Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.
  138068-37-8
  Y43GF64R34
  liquid
  
    approved
  
  
    
      
A1 16244762 Smythe MA, Stephens JL, Koerber JM, Mattson JC: A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost. 2005 Oct;11(4):371-4.
A2 16690967 Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V: Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood. 2006 Sep 1;108(5):1492-6. Epub 2006 May 11.
A3 16241940 Lubenow N, Eichler P, Lietz T, Greinacher A: Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost. 2005 Nov;3(11):2428-36.
L48 Google books http://books.google.com/books?id=iadLoXoQkWEC&pg=PA440
For the treatment of heparin-induced thrombocytopenia Lepirudin is used to break up clots and to reduce thrombocytopenia. It binds to thrombin and prevents thrombus or clot formation. It is a highly potent, selective, and essentially irreversible inhibitor of thrombin and clot-bond thrombin. Lepirudin requires no cofactor for its anticoagulant action. Lepirudin is a recombinant form of hirudin, an endogenous anticoagulant found in medicinal leeches. Lepirudin forms a stable non-covalent complex with alpha-thrombin, thereby abolishing its ability to cleave fibrinogen and initiate the clotting cascade. The inhibition of thrombin prevents the blood clotting cascade. In case of overdose (eg, suggested by excessively high aPTT values) the risk of bleeding is increased. Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis of the parent drug. However, con-clusive data are not available. About 48% of the administration dose is excreted in the urine which consists of unchanged drug (35%) and other fragments of the parent drug. Bioavailability is 100% following injection. Approximately 1.3 hours Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis of the parent drug. About 48% of the administration dose is excreted in the urine which consists of unchanged drug (35%) and other fragments of the parent drug. * 12.2 L [Healthy young subjects (n = 18, age 18-60 years)] * 18.7 L [Healthy elderly subjects (n = 10, age 65-80 years)] * 18 L [Renally impaired patients (n = 16, creatinine clearance below 80 mL/min)] * 32.1 L [HIT patients (n = 73)] * 164 ml/min [Healthy 18-60 yrs] * 139 ml/min [Healthy 65-80 yrs] * 61 ml/min [renal impaired] * 114 ml/min [HIT (Heparin-induced thrombocytopenia)] Peptides Organic Compounds Organic Acids Carboxylic Acids and Derivatives Amino Acids, Peptides, and Analogues Hirudin variant-1 Lepirudin Lepirudin recombinant Refludan Bayer 50419-150 1998-03-06 2013-06-30 Powder 50 mg/1mL Intravenous NDA020807 false false true US FDA NDC Refludan Bayer 02240996 2000-01-31 2013-07-26 Powder, for solution 50 mg / vial Intravenous false false true Canada DPD Refludan Celgene Europe Limited EMEA/H/C/000122 EU/1/97/035/001 2016-09-08 2012-07-27 Injection, solution, concentrate 50 mg Intravenous false false false EU EMA Refludan Celgene Europe Limited EMEA/H/C/000122 EU/1/97/035/002 2016-09-08 2012-07-27 Injection, solution, concentrate 50 mg Intravenous false false false EU EMA Refludan Celgene Europe Limited EMEA/H/C/000122 EU/1/97/035/003 2016-09-08 2012-07-27 Injection, solution, concentrate 20 mg Intravenous false false false EU EMA Refludan Celgene Europe Limited EMEA/H/C/000122 EU/1/97/035/004 2016-09-08 2012-07-27 Injection, solution, concentrate 20 mg Intravenous false false false EU EMA Refludan Lepirudin Refludan Lepirudin Refludan Lepirudin Refludan Lepirudin Refludan Lepirudin Refludan Lepirudin Bayer Healthcare http://www.bayerhealthcare.com Berlex Labs http://www.berlex.com Bayer healthcare pharmaceuticals inc Refludan 50 mg vial 273.19 vial Amino Acids, Peptides, and Proteins D000602 Anticoagulants D000925 Antithrombin Proteins D058833 Antithrombins D000991 Blood and Blood Forming Organs Cardiovascular Agents D002317 Enzyme Inhibitors D004791 Fibrin Modulating Agents D050299 Hematologic Agents D006401 Peptides D010455 Protease Inhibitors D011480 Proteins D011506 Serine Protease Inhibitors D015842 Serpins D015843 Thrombin Inhibitors Humans and other mammals
Injection, powder, for suspension
Intravenous 50 mg
Injection, solution, concentrate
Intravenous 20 mg
Injection, solution, concentrate
Intravenous 50 mg
Powder
Intravenous
Powder
Intravenous 50 mg/1mL
Powder, for solution
Intravenous 50 mg / vial
Direct thrombin inhibitors ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS BLOOD AND BLOOD FORMING ORGANS //s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00001.pdf?1265924858 //s3-us-west-2.amazonaws.com/drugbank/msds/DB00001.pdf?1368416245 5180668 United States 1993-01-19 2010-01-19 false Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba. DB06605 Apixaban Apixaban may increase the anticoagulant activities of Lepirudin. DB06695 Dabigatran etexilate Dabigatran etexilate may increase the anticoagulant activities of Lepirudin. DB01254 Dasatinib The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Lepirudin. DB01609 Deferasirox The risk or severity of gastrointestinal bleeding can be increased when Lepirudin is combined with Deferasirox. DB01586 Ursodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Ursodeoxycholic acid. DB02123 Glycochenodeoxycholic Acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycochenodeoxycholic Acid. DB02659 Cholic Acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Cholic Acid. DB02691 Glycocholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycocholic acid. DB03619 Deoxycholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Deoxycholic acid. DB04348 Taurocholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurocholic acid. DB05990 Obeticholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Obeticholic acid. DB06777 Chenodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Chenodeoxycholic acid. DB08833 Taurochenodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid. DB08834 Tauroursodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid. DB08857 Bamet-UD2 The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Bamet-UD2. DB11622 Dehydrocholic acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Dehydrocholic acid. DB11789 Hyodeoxycholic Acid The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Hyodeoxycholic Acid. DB09075 Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Lepirudin. DB09053 Ibrutinib The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Lepirudin. DB08935 Obinutuzumab The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Obinutuzumab. DB06228 Rivaroxaban Lepirudin may increase the anticoagulant activities of Rivaroxaban. DB06206 Sugammadex The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Sugammadex. DB09070 Tibolone Tibolone may increase the anticoagulant activities of Lepirudin. DB00932 Tipranavir The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Lepirudin. DB00013 Urokinase Urokinase may increase the anticoagulant activities of Lepirudin. DB00163 Vitamin E Vitamin E may increase the anticoagulant activities of Lepirudin. DB09030 Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Lepirudin. DB01381 Ginkgo biloba Ginkgo biloba may increase the anticoagulant activities of Lepirudin. DB01181 Ifosfamide The risk or severity of bleeding can be increased when Ifosfamide is combined with Lepirudin. DB00468 Quinine The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinine. DB00908 Quinidine The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine. DB00675 Tamoxifen The risk or severity of bleeding can be increased when Tamoxifen is combined with Lepirudin. DB00539 Toremifene The risk or severity of bleeding can be increased when Toremifene is combined with Lepirudin. DB00806 Pentoxifylline The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline. DB00686 Pentosan polysulfate Pentosan polysulfate may increase the anticoagulant activities of Lepirudin. DB00583 Levocarnitine The therapeutic efficacy of Lepirudin can be increased when used in combination with Levocarnitine. DB00255 Diethylstilbestrol Diethylstilbestrol may decrease the anticoagulant activities of Lepirudin. DB00269 Chlorotrianisene Chlorotrianisene may decrease the anticoagulant activities of Lepirudin. DB00286 Conjugated estrogens Conjugated estrogens may decrease the anticoagulant activities of Lepirudin. DB01357 Mestranol Mestranol may decrease the anticoagulant activities of Lepirudin. DB04574 Estrone sulfate Estrone sulfate may decrease the anticoagulant activities of Lepirudin. DB04575 Quinestrol Quinestrol may decrease the anticoagulant activities of Lepirudin. DB07931 Hexestrol Hexestrol may decrease the anticoagulant activities of Lepirudin. DB09317 Synthetic Conjugated Estrogens, A Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Lepirudin. DB09318 Synthetic Conjugated Estrogens, B Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Lepirudin. DB09369 Polyestradiol phosphate Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin. DB09381 Esterified estrogens Esterified estrogens may decrease the anticoagulant activities of Lepirudin. DB11478 Zeranol Zeranol may decrease the anticoagulant activities of Lepirudin. DB11674 Equol Equol may decrease the anticoagulant activities of Lepirudin. DB13143 Methallenestril Methallenestril may decrease the anticoagulant activities of Lepirudin. DB13386 Epimestrol Epimestrol may decrease the anticoagulant activities of Lepirudin. DB13418 Moxestrol Moxestrol may decrease the anticoagulant activities of Lepirudin. DB13952 Estradiol acetate Estradiol acetate may decrease the anticoagulant activities of Lepirudin. DB13953 Estradiol benzoate Estradiol benzoate may decrease the anticoagulant activities of Lepirudin. DB13954 Estradiol cypionate Estradiol cypionate may decrease the anticoagulant activities of Lepirudin. DB13956 Estradiol valerate Estradiol valerate may decrease the anticoagulant activities of Lepirudin. DB15334 Biochanin A Biochanin A may decrease the anticoagulant activities of Lepirudin. DB15335 Formononetin Formononetin may decrease the anticoagulant activities of Lepirudin. DB04573 Estriol Estriol may decrease the anticoagulant activities of Lepirudin. DB09211 Limaprost The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin. DB00159 Icosapent The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Lepirudin. DB00244 Mesalazine The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Lepirudin. DB00328 Indomethacin The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Lepirudin. DB00461 Nabumetone The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Lepirudin. DB00465 Ketorolac The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Lepirudin. DB00469 Tenoxicam The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Lepirudin. DB00482 Celecoxib The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Lepirudin. DB00500 Tolmetin The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Lepirudin. DB00533 Rofecoxib The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Lepirudin. DB00554 Piroxicam The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Lepirudin. DB00573 Fenoprofen The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Lepirudin. DB00580 Valdecoxib The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Lepirudin. DB00586 Diclofenac The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Lepirudin. DB00605 Sulindac The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Lepirudin. DB00712 Flurbiprofen The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Lepirudin. DB00749 Etodolac The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Lepirudin. DB00784 Mefenamic acid The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Lepirudin. DB00788 Naproxen The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Lepirudin. DB00795 Sulfasalazine The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Lepirudin. DB00812 Phenylbutazone The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Lepirudin. DB00814 Meloxicam The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Lepirudin. DB00821 Carprofen The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Lepirudin. DB00861 Diflunisal The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Lepirudin. DB00936 Salicylic acid The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Lepirudin. DB00939 Meclofenamic acid The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Lepirudin. DB00991 Oxaprozin The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Lepirudin. DB01009 Ketoprofen The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Lepirudin. DB01014 Balsalazide The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Lepirudin. DB01250 Olsalazine The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Lepirudin. DB01283 Lumiracoxib The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Lepirudin. DB01397 Magnesium salicylate The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Lepirudin. DB01399 Salsalate The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Lepirudin. DB01401 Choline magnesium trisalicylate The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Lepirudin. DB01419 Antrafenine The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Lepirudin. DB01424 Aminophenazone The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Lepirudin. DB01435 Antipyrine The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Lepirudin. DB01600 Tiaprofenic acid The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Lepirudin. DB01628 Etoricoxib The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Lepirudin. DB02224 Taxifolin The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Lepirudin. DB03585 Oxyphenbutazone The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Lepirudin. DB04725 Licofelone The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Lepirudin. DB04812 Benoxaprofen The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Lepirudin. DB04817 Metamizole The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Lepirudin. DB04828 Zomepirac The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Lepirudin. DB05095 Cimicoxib The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Lepirudin. DB06725 Lornoxicam The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Lepirudin. DB06736 Aceclofenac The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Lepirudin. DB06737 Zaltoprofen The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Lepirudin. DB07402 Azapropazone The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Lepirudin. DB08439 Parecoxib The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Lepirudin. DB08797 Salicylamide The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Lepirudin. DB08940 Kebuzone The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Lepirudin. DB08942 Isoxicam The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Lepirudin. DB08951 Indoprofen The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Lepirudin. DB08955 Ibuproxam The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Lepirudin. DB08976 Floctafenine The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Lepirudin. DB08981 Fenbufen The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin. DB08984 Etofenamate The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Lepirudin. DB08991 Epirizole The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Lepirudin. DB09084 Benzydamine The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Lepirudin. DB09214 Dexketoprofen The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Lepirudin. DB09215 Droxicam The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Lepirudin. DB09216 Tolfenamic acid The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Lepirudin. DB09217 Firocoxib The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Lepirudin. DB09218 Clonixin The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Lepirudin. DB09285 Morniflumate The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Lepirudin. DB09288 Propacetamol The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Lepirudin. DB09295 Talniflumate The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Lepirudin. DB11455 Robenacoxib The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Lepirudin. DB11466 Tepoxalin The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Lepirudin. DB11518 Flunixin The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Lepirudin. DB12399 Polmacoxib The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Lepirudin. DB12610 Ebselen The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Lepirudin. DB13001 Tinoridine The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Lepirudin. DB13167 Alclofenac The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Lepirudin. DB13217 Fentiazac The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Lepirudin. DB13232 Suxibuzone The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Lepirudin. DB13286 Bumadizone The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Lepirudin. DB13314 Alminoprofen The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Lepirudin. DB13371 Difenpiramide The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Lepirudin. DB13407 Nifenazone The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Lepirudin. DB13432 Lonazolac The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Lepirudin. DB13481 Tenidap The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Lepirudin. DB13524 Propyphenazone The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Lepirudin. DB13527 Proglumetacin The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Lepirudin. DB13538 Guacetisal The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Lepirudin. DB13544 Ethenzamide The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Lepirudin. DB13612 Carbaspirin calcium The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Lepirudin. DB13629 Mofebutazone The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Lepirudin. DB13649 Proquazone The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Lepirudin. DB13657 Benorilate The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Lepirudin. DB13722 Pirprofen The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Lepirudin. DB13860 Imidazole salicylate The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Lepirudin. DB14059 SC-236 The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Lepirudin. DB14060 NS-398 The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Lepirudin. DB14938 Flurbiprofen axetil The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Lepirudin. DB09212 Loxoprofen The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Lepirudin. DB04552 Niflumic acid The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Lepirudin. DB04865 Omacetaxine mepesuccinate The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate. DB11133 Omega-3 fatty acids Omega-3 fatty acids may increase the anticoagulant activities of Lepirudin. DB00081 Tositumomab The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab. DB00048 Collagenase clostridium histolyticum The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum. DB00389 Carbimazole Carbimazole may increase the anticoagulant activities of Lepirudin. DB00550 Propylthiouracil Propylthiouracil may increase the anticoagulant activities of Lepirudin. DB00763 Methimazole Methimazole may increase the anticoagulant activities of Lepirudin. DB03374 3,5-Diiodotyrosine 3,5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin. DB06715 Potassium Iodide Potassium Iodide may increase the anticoagulant activities of Lepirudin. DB07637 Dibromotyrosine Dibromotyrosine may increase the anticoagulant activities of Lepirudin. DB09418 Potassium perchlorate Potassium perchlorate may increase the anticoagulant activities of Lepirudin. DB13644 Methylthiouracil Methylthiouracil may increase the anticoagulant activities of Lepirudin. DB13804 Benzylthiouracil Benzylthiouracil may increase the anticoagulant activities of Lepirudin. DB04066 p-Coumaric acid The therapeutic efficacy of Lepirudin can be decreased when used in combination with p-Coumaric acid. DB04682 Octylphenoxy polyethoxyethanol The therapeutic efficacy of Lepirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol. DB05830 Trestolone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trestolone. DB06266 Lonidamine The therapeutic efficacy of Lepirudin can be decreased when used in combination with Lonidamine. DB08867 Ulipristal The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ulipristal. DB11507 Cloprostenol The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cloprostenol. DB12025 Triptolide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triptolide. DB13044 Gossypol The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gossypol. DB00294 Etonogestrel The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etonogestrel. DB00378 Dydrogesterone Dydrogesterone may decrease the anticoagulant activities of Lepirudin. DB00396 Progesterone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Progesterone. DB01431 Allylestrenol Allylestrenol may decrease the anticoagulant activities of Lepirudin. DB06713 Norelgestromin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Norelgestromin. DB06789 Hydroxyprogesterone caproate The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroxyprogesterone caproate. DB09124 Medrogestone Medrogestone may decrease the anticoagulant activities of Lepirudin. DB11372 Altrenogest Altrenogest may decrease the anticoagulant activities of Lepirudin. DB11636 Nomegestrol The therapeutic efficacy of Lepirudin can be decreased when used in combination with Nomegestrol. DB13230 Gestonorone Gestonorone may decrease the anticoagulant activities of Lepirudin. DB13533 Methylestrenolone Methylestrenolone may decrease the anticoagulant activities of Lepirudin. DB13602 Promegestone Promegestone may decrease the anticoagulant activities of Lepirudin. DB13866 Etynodiol The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etynodiol. DB14570 Hydroxyprogesterone Hydroxyprogesterone may decrease the anticoagulant activities of Lepirudin. DB14679 Quingestanol acetate Quingestanol acetate may decrease the anticoagulant activities of Lepirudin. DB00233 Aminosalicylic acid The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin. DB01294 Bismuth subsalicylate The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin. DB06251 Dersalazine The risk or severity of bleeding can be increased when Dersalazine is combined with Lepirudin. DB06807 Phenyl aminosalicylate The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Lepirudin. DB09543 Methyl salicylate The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin. DB11079 Trolamine salicylate The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Lepirudin. DB13509 Aloxiprin The risk or severity of bleeding can be increased when Aloxiprin is combined with Lepirudin. DB14006 Choline salicylate The risk or severity of bleeding can be increased when Choline salicylate is combined with Lepirudin. DB14026 Thiosalicylic acid The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Lepirudin. DB00054 Abciximab The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin. DB00063 Eptifibatide The risk or severity of bleeding can be increased when Eptifibatide is combined with Lepirudin. DB00208 Ticlopidine The risk or severity of bleeding can be increased when Ticlopidine is combined with Lepirudin. DB00261 Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin. DB00758 Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin. DB00775 Tirofiban The risk or severity of bleeding can be increased when Tirofiban is combined with Lepirudin. DB00975 Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Lepirudin. DB01088 Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Lepirudin. DB01138 Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lepirudin. DB01166 Cilostazol The risk or severity of bleeding can be increased when Cilostazol is combined with Lepirudin. DB01207 Ridogrel The risk or severity of bleeding can be increased when Ridogrel is combined with Lepirudin. DB01236 Sevoflurane The risk or severity of bleeding can be increased when Sevoflurane is combined with Lepirudin. DB01240 Epoprostenol The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin. DB02709 Resveratrol The risk or severity of bleeding can be increased when Resveratrol is combined with Lepirudin. DB04743 Nimesulide The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Lepirudin. DB04905 Tesmilifene The risk or severity of bleeding can be increased when Tesmilifene is combined with Lepirudin. DB04932 Defibrotide The risk or severity of bleeding can be increased when Defibrotide is combined with Lepirudin. DB05229 Beraprost The risk or severity of bleeding can be increased when Beraprost is combined with Lepirudin. DB05266 Ibudilast The risk or severity of bleeding can be increased when Ibudilast is combined with Lepirudin. DB05767 Andrographolide The risk or severity of bleeding can be increased when Andrographolide is combined with Lepirudin. DB06081 Caplacizumab The risk or severity of bleeding can be increased when Caplacizumab is combined with Lepirudin. DB06209 Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Lepirudin. DB06441 Cangrelor The risk or severity of bleeding can be increased when Cangrelor is combined with Lepirudin. DB07615 Tranilast The risk or severity of bleeding can be increased when Tranilast is combined with Lepirudin. DB08814 Triflusal The risk or severity of bleeding can be increased when Triflusal is combined with Lepirudin. DB08816 Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Lepirudin. DB08887 Icosapent ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Lepirudin. DB09283 Trapidil The risk or severity of bleeding can be increased when Trapidil is combined with Lepirudin. DB12092 Naftopidil The risk or severity of bleeding can be increased when Naftopidil is combined with Lepirudin. DB12163 Sarpogrelate The risk or severity of bleeding can be increased when Sarpogrelate is combined with Lepirudin. DB12321 Ifetroban The risk or severity of bleeding can be increased when Ifetroban is combined with Lepirudin. DB12445 Nitroaspirin The risk or severity of bleeding and hemorrhage can be increased when Nitroaspirin is combined with Lepirudin. DB12465 Ketanserin The risk or severity of bleeding can be increased when Ketanserin is combined with Lepirudin. DB12545 Indobufen The risk or severity of bleeding and hemorrhage can be increased when Indobufen is combined with Lepirudin. DB12749 Butylphthalide The risk or severity of bleeding can be increased when Butylphthalide is combined with Lepirudin. DB12771 Hydroxytyrosol The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Lepirudin. DB13036 Ramatroban The risk or severity of bleeding can be increased when Ramatroban is combined with Lepirudin. DB13327 Picotamide The risk or severity of bleeding can be increased when Picotamide is combined with Lepirudin. DB13367 Cloricromen The risk or severity of bleeding can be increased when Cloricromen is combined with Lepirudin. DB13400 Linsidomine The risk or severity of bleeding can be increased when Linsidomine is combined with Lepirudin. DB13510 Buflomedil The risk or severity of bleeding can be increased when Buflomedil is combined with Lepirudin. DB13929 Relcovaptan The risk or severity of bleeding can be increased when Relcovaptan is combined with Lepirudin. DB15786 Maritime pine extract The risk or severity of bleeding can be increased when Maritime pine extract is combined with Lepirudin. DB00374 Treprostinil The risk or severity of bleeding can be increased when Treprostinil is combined with Lepirudin. DB03404 Hemin Hemin may increase the anticoagulant activities of Lepirudin. DB13783 Acemetacin The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Acemetacin. DB00624 Testosterone Testosterone may increase the anticoagulant activities of Lepirudin. DB01420 Testosterone propionate Testosterone propionate may increase the anticoagulant activities of Lepirudin. DB01481 1-Testosterone 1-Testosterone may increase the anticoagulant activities of Lepirudin. DB01485 4-Hydroxytestosterone 4-Hydroxytestosterone may increase the anticoagulant activities of Lepirudin. DB01510 Dehydrochloromethyltestosterone Dehydrochloromethyltestosterone may increase the anticoagulant activities of Lepirudin. DB01541 Boldenone Boldenone may increase the anticoagulant activities of Lepirudin. DB01543 18-methyl-19-nortestosterone 18-methyl-19-nortestosterone may increase the anticoagulant activities of Lepirudin. DB01564 Calusterone Calusterone may increase the anticoagulant activities of Lepirudin. DB01569 Formebolone Formebolone may increase the anticoagulant activities of Lepirudin. DB01572 Methyl-1-testosterone Methyl-1-testosterone may increase the anticoagulant activities of Lepirudin. DB07447 5beta-dihydrotestosterone 5beta-dihydrotestosterone may increase the anticoagulant activities of Lepirudin. DB08619 Testosterone succinate Testosterone succinate may increase the anticoagulant activities of Lepirudin. DB11429 Mibolerone Mibolerone may increase the anticoagulant activities of Lepirudin. DB13943 Testosterone cypionate Testosterone cypionate may increase the anticoagulant activities of Lepirudin. DB13944 Testosterone enanthate Testosterone enanthate may increase the anticoagulant activities of Lepirudin. DB13946 Testosterone undecanoate Testosterone undecanoate may increase the anticoagulant activities of Lepirudin. DB13947 Testosterone enantate benzilic acid hydrazone Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Lepirudin. DB13951 Stanolone acetate Stanolone acetate may increase the anticoagulant activities of Lepirudin. DB13958 Trestolone acetate Trestolone acetate may increase the anticoagulant activities of Lepirudin. DB14093 (1,2,6,7-3H)Testosterone (1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Lepirudin. DB14655 Drostanolone propionate Drostanolone propionate may increase the anticoagulant activities of Lepirudin. DB02901 Stanolone Stanolone may increase the anticoagulant activities of Lepirudin. DB11051 Azficel-T The risk or severity of adverse effects can be increased when Lepirudin is combined with Azficel-T. DB09568 Omega-3-carboxylic acids The therapeutic efficacy of Lepirudin can be increased when used in combination with Omega-3-carboxylic acids. DB00025 Antihemophilic factor, human recombinant The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin. DB00036 Coagulation factor VIIa Recombinant Human The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin. DB00100 Coagulation Factor IX (Recombinant) The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Lepirudin. DB00258 Calcium acetate The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Lepirudin. DB01164 Calcium chloride The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Lepirudin. DB01373 Calcium The therapeutic efficacy of Calcium can be decreased when used in combination with Lepirudin. DB01783 Pantothenic acid The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Lepirudin. DB01942 Formic acid The therapeutic efficacy of Formic acid can be decreased when used in combination with Lepirudin. DB02261 Platelet Activating Factor The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Lepirudin. DB06724 Calcium carbonate The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Lepirudin. DB09109 Turoctocog alfa The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Lepirudin. DB09222 Fibrinogen human The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Lepirudin. DB09310 Catridecacog The therapeutic efficacy of Catridecacog can be decreased when used in combination with Lepirudin. DB09329 Antihemophilic factor (recombinant), PEGylated The therapeutic efficacy of Antihemophilic factor (recombinant), PEGylated can be decreased when used in combination with Lepirudin. DB11093 Calcium citrate The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Lepirudin. DB11126 Calcium gluconate The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Lepirudin. DB11168 Calcium threonate The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Lepirudin. DB11311 Prothrombin The therapeutic efficacy of Prothrombin can be decreased when used in combination with Lepirudin. DB11330 Factor IX Complex (Human) The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Lepirudin. DB11348 Calcium Phosphate The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lepirudin. DB11606 Susoctocog alfa The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Lepirudin. DB11608 Eftrenonacog alfa The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Lepirudin. DB11668 Rusalatide acetate The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Lepirudin. DB12409 Vatreptacog alfa The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Lepirudin. DB12909 Factor XIII (human) The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Lepirudin. DB13133 Von Willebrand factor human The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Lepirudin. DB13148 Coagulation factor X human The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Lepirudin. DB13150 Coagulation factor VII human The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Lepirudin. DB13151 Anti-inhibitor coagulant complex The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Lepirudin. DB13152 Coagulation Factor IX Human The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Lepirudin. DB13192 Antihemophilic factor human The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Lepirudin. DB13197 Kallidinogenase The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin. DB13201 Trenonacog alfa The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Lepirudin. DB13884 Albutrepenonacog alfa The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Lepirudin. DB13923 Emicizumab The therapeutic efficacy of Emicizumab can be decreased when used in combination with Lepirudin. DB13933 Nonacog beta pegol The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Lepirudin. DB13999 Moroctocog alfa The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Lepirudin. DB14473 Beroctocog alfa The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Lepirudin. DB14562 Andexanet alfa The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Lepirudin. DB14577 Calcium cation The therapeutic efficacy of Calcium cation can be decreased when used in combination with Lepirudin. DB14700 Damoctocog alfa pegol The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Lepirudin. DB14738 Turoctocog alfa pegol The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Lepirudin. DB00176 Fluvoxamine The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Lepirudin. DB00215 Citalopram The risk or severity of hemorrhage can be increased when Citalopram is combined with Lepirudin. DB00472 Fluoxetine The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Lepirudin. DB00715 Paroxetine The risk or severity of hemorrhage can be increased when Paroxetine is combined with Lepirudin. DB01149 Nefazodone The risk or severity of hemorrhage can be increased when Nefazodone is combined with Lepirudin. DB04832 Zimelidine The risk or severity of hemorrhage can be increased when Zimelidine is combined with Lepirudin. DB04884 Dapoxetine The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Lepirudin. DB06731 Seproxetine The risk or severity of hemorrhage can be increased when Seproxetine is combined with Lepirudin. DB08953 Indalpine The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin. DB12693 Ritanserin The risk or severity of hemorrhage can be increased when Ritanserin is combined with Lepirudin. DB13233 Alaproclate The risk or severity of hemorrhage can be increased when Alaproclate is combined with Lepirudin. DB00476 Duloxetine The risk or severity of hemorrhage can be increased when Duloxetine is combined with Lepirudin. DB01105 Sibutramine The risk or severity of hemorrhage can be increased when Sibutramine is combined with Lepirudin. DB04896 Milnacipran The risk or severity of hemorrhage can be increased when Milnacipran is combined with Lepirudin. DB06700 Desvenlafaxine The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Lepirudin. DB08918 Levomilnacipran The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Lepirudin. DB00285 Venlafaxine Venlafaxine may increase the antiplatelet activities of Lepirudin. DB00601 Linezolid The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin. DB00614 Furazolidone The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Lepirudin. DB00721 Procaine The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin. DB00752 Tranylcypromine The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Lepirudin. DB00780 Phenelzine The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Lepirudin. DB00805 Minaprine The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Lepirudin. DB01037 Selegiline The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Lepirudin. DB01168 Procarbazine The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Lepirudin. DB01171 Moclobemide The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Lepirudin. DB01247 Isocarboxazid The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Lepirudin. DB01367 Rasagiline The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Lepirudin. DB01626 Pargyline The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Lepirudin. DB04017 Clorgiline The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Lepirudin. DB04818 Iproniazid The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Lepirudin. DB04820 Nialamide The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Lepirudin. DB06654 Safinamide The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Lepirudin. DB08550 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Lepirudin. DB09241 Methylene blue The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Lepirudin. DB09243 Hydracarbazine The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Lepirudin. DB09244 Pirlindole The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Lepirudin. DB09245 Toloxatone The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Lepirudin. DB09246 Benmoxin The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Lepirudin. DB09248 Mebanazine The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Lepirudin. DB09249 Octamoxin The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Lepirudin. DB09250 Pheniprazine The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Lepirudin. DB09251 Phenoxypropazine The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Lepirudin. DB09252 Pivhydrazine The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Lepirudin. DB09253 Safrazine The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Lepirudin. DB09254 Caroxazone The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Lepirudin. DB13875 Harmaline The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Lepirudin. DB13876 Brofaromine The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Lepirudin. DB00006 Bivalirudin The risk or severity of bleeding can be increased when Lepirudin is combined with Bivalirudin. DB00266 Dicoumarol The risk or severity of bleeding can be increased when Lepirudin is combined with Dicoumarol. DB00278 Argatroban The risk or severity of bleeding can be increased when Lepirudin is combined with Argatroban. DB00407 Ardeparin The risk or severity of bleeding can be increased when Lepirudin is combined with Ardeparin. DB00498 Phenindione The risk or severity of bleeding can be increased when Lepirudin is combined with Phenindione. DB00569 Fondaparinux The risk or severity of bleeding can be increased when Lepirudin is combined with Fondaparinux. DB00682 Warfarin The risk or severity of bleeding can be increased when Lepirudin is combined with Warfarin. DB00946 Phenprocoumon The risk or severity of bleeding can be increased when Lepirudin is combined with Phenprocoumon. DB00974 Edetic acid The risk or severity of bleeding can be increased when Lepirudin is combined with Edetic acid. DB01109 Heparin The risk or severity of bleeding can be increased when Lepirudin is combined with Heparin. DB01225 Enoxaparin The risk or severity of bleeding can be increased when Lepirudin is combined with Enoxaparin. DB01418 Acenocoumarol The risk or severity of bleeding can be increased when Lepirudin is combined with Acenocoumarol. DB04898 Ximelagatran The risk or severity of bleeding can be increased when Lepirudin is combined with Ximelagatran. DB05099 Ancrod The risk or severity of bleeding can be increased when Lepirudin is combined with Ancrod. DB06271 Sulodexide The risk or severity of bleeding can be increased when Lepirudin is combined with Sulodexide. DB06406 Idraparinux The risk or severity of bleeding can be increased when Lepirudin is combined with Idraparinux. DB06635 Otamixaban The risk or severity of bleeding can be increased when Lepirudin is combined with Otamixaban. DB06754 Danaparoid The risk or severity of bleeding can be increased when Lepirudin is combined with Danaparoid. DB06779 Dalteparin The risk or severity of bleeding can be increased when Lepirudin is combined with Dalteparin. DB07767 Ferulic acid The risk or severity of bleeding can be increased when Lepirudin is combined with Ferulic acid. DB08794 Ethyl biscoumacetate The risk or severity of bleeding can be increased when Lepirudin is combined with Ethyl biscoumacetate. DB08813 Nadroparin The risk or severity of bleeding can be increased when Lepirudin is combined with Nadroparin. DB09255 Dextran The risk or severity of bleeding can be increased when Lepirudin is combined with Dextran. DB11095 Desirudin The risk or severity of bleeding can be increased when Lepirudin is combined with Desirudin. DB11268 Protocatechualdehyde The risk or severity of bleeding can be increased when Lepirudin is combined with Protocatechualdehyde. DB11312 Protein C The risk or severity of bleeding can be increased when Lepirudin is combined with Protein C. DB11598 Antithrombin III human The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin III human. DB11984 Letaxaban The risk or severity of bleeding can be increased when Lepirudin is combined with Letaxaban. DB12289 Darexaban The risk or severity of bleeding can be increased when Lepirudin is combined with Darexaban. DB12598 Nafamostat The risk or severity of bleeding can be increased when Lepirudin is combined with Nafamostat. DB12831 Gabexate The risk or severity of bleeding can be increased when Lepirudin is combined with Gabexate. DB13124 Troxerutin The risk or severity of bleeding can be increased when Lepirudin is combined with Troxerutin. DB13136 Fluindione The risk or severity of bleeding can be increased when Lepirudin is combined with Fluindione. DB13149 Protein S human The risk or severity of bleeding can be increased when Lepirudin is combined with Protein S human. DB13616 Melagatran The risk or severity of bleeding can be increased when Lepirudin is combined with Melagatran. DB09125 Potassium citrate The risk or severity of bleeding can be increased when Lepirudin is combined with Potassium citrate. DB09154 Sodium citrate The risk or severity of bleeding can be increased when Lepirudin is combined with Sodium citrate. DB00031 Tenecteplase The risk or severity of bleeding can be increased when Lepirudin is combined with Tenecteplase. DB00055 Drotrecogin alfa The risk or severity of bleeding can be increased when Lepirudin is combined with Drotrecogin alfa. DB06822 Tinzaparin The risk or severity of bleeding can be increased when Lepirudin is combined with Tinzaparin. DB13199 Brinase The risk or severity of bleeding can be increased when Lepirudin is combined with Brinase. DB13646 Saruplase The risk or severity of bleeding can be increased when Lepirudin is combined with Saruplase. DB00086 Streptokinase The risk or severity of bleeding can be increased when Lepirudin is combined with Streptokinase. DB04925 Desmoteplase The risk or severity of bleeding can be increased when Lepirudin is combined with Desmoteplase. DB05254 Fibrinolysin The risk or severity of bleeding can be increased when Lepirudin is combined with Fibrinolysin. DB06543 Astaxanthin The risk or severity of bleeding can be increased when Lepirudin is combined with Astaxanthin. DB08994 Ditazole The risk or severity of bleeding can be increased when Lepirudin is combined with Ditazole. DB09258 Bemiparin The risk or severity of bleeding can be increased when Lepirudin is combined with Bemiparin. DB09260 Parnaparin The risk or severity of bleeding can be increased when Lepirudin is combined with Parnaparin. DB13275 Clorindione The risk or severity of bleeding can be increased when Lepirudin is combined with Clorindione. DB13347 Diphenadione The risk or severity of bleeding can be increased when Lepirudin is combined with Diphenadione. DB13451 Tioclomarol The risk or severity of bleeding can be increased when Lepirudin is combined with Tioclomarol. DB00009 Alteplase The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase. DB00015 Reteplase The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase. DB00029 Anistreplase The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase. DB14094 Tocopherylquinone The risk or severity of bleeding can be increased when Lepirudin is combined with Tocopherylquinone. DB06679 Amediplase The risk or severity of bleeding can be increased when Lepirudin is combined with Amediplase. DB03410 4-hydroxycoumarin The risk or severity of bleeding can be increased when Lepirudin is combined with 4-hydroxycoumarin. DB08496 (R)-warfarin The risk or severity of bleeding can be increased when Lepirudin is combined with (R)-warfarin. DB14055 (S)-Warfarin The risk or severity of bleeding can be increased when Lepirudin is combined with (S)-Warfarin. DB12364 Betrixaban The risk or severity of bleeding can be increased when Lepirudin is combined with Betrixaban. DB14598 Edetate calcium disodium anhydrous The risk or severity of bleeding can be increased when Lepirudin is combined with Edetate calcium disodium anhydrous. DB11154 Zinc citrate The risk or severity of bleeding can be increased when Lepirudin is combined with Zinc citrate. DB11166 Antithrombin Alfa The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin Alfa. DB04665 Coumarin The risk or severity of bleeding can be increased when Lepirudin is combined with Coumarin. DB14726 Dabigatran The risk or severity of bleeding can be increased when Lepirudin is combined with Dabigatran. DB06294 Semuloparin The risk or severity of bleeding can be increased when Lepirudin is combined with Semuloparin. DB12726 Monteplase The risk or severity of bleeding can be increased when Lepirudin is combined with Monteplase. DB09259 Reviparin The risk or severity of bleeding can be increased when Lepirudin is combined with Reviparin. DB15880 Dermatan sulfate The risk or severity of bleeding can be increased when Lepirudin is combined with Dermatan sulfate. DB05361 SR-123781A The risk or severity of bleeding can be increased when Lepirudin is combined with SR-123781A. DB16481 Dociparstat sodium The risk or severity of bleeding can be increased when Lepirudin is combined with Dociparstat sodium. DB00203 Sildenafil The risk or severity of hemorrhage can be increased when Lepirudin is combined with Sildenafil. DB00008 Peginterferon alfa-2a The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a. DB00011 Interferon alfa-n1 The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1. DB00018 Interferon alfa-n3 The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3. DB00022 Peginterferon alfa-2b The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b. DB00033 Interferon gamma-1b The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b. DB00034 Interferon alfa-2a The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a. DB00041 Aldesleukin The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin. DB00056 Gemtuzumab ozogamicin The risk or severity of bleeding can be increased when Lepirudin is combined with Gemtuzumab ozogamicin. DB00068 Interferon beta-1b The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon beta-1b. DB00069 Interferon alfacon-1 The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfacon-1. DB00073 Rituximab The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab. DB00078 Ibritumomab tiuxetan The risk or severity of bleeding can be increased when Lepirudin is combined with Ibritumomab tiuxetan. DB00087 Alemtuzumab The risk or severity of bleeding can be increased when Lepirudin is combined with Alemtuzumab. DB00105 Interferon alfa-2b The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2b. DB00120 Phenylalanine The risk or severity of bleeding can be increased when Lepirudin is combined with Phenylalanine. DB00188 Bortezomib The risk or severity of bleeding can be increased when Lepirudin is combined with Bortezomib. DB00242 Cladribine The risk or severity of bleeding can be increased when Lepirudin is combined with Cladribine. DB00262 Carmustine The risk or severity of bleeding can be increased when Lepirudin is combined with Carmustine. DB00276 Amsacrine The risk or severity of bleeding can be increased when Lepirudin is combined with Amsacrine. DB00291 Chlorambucil The risk or severity of bleeding can be increased when Lepirudin is combined with Chlorambucil. DB00293 Raltitrexed The risk or severity of bleeding can be increased when Lepirudin is combined with Raltitrexed. DB00305 Mitomycin The risk or severity of bleeding can be increased when Lepirudin is combined with Mitomycin. DB00307 Bexarotene The risk or severity of bleeding can be increased when Lepirudin is combined with Bexarotene. DB00309 Vindesine The risk or severity of bleeding can be increased when Lepirudin is combined with Vindesine. DB00322 Floxuridine The risk or severity of bleeding can be increased when Lepirudin is combined with Floxuridine. DB00352 Tioguanine The risk or severity of bleeding can be increased when Lepirudin is combined with Tioguanine. DB00361 Vinorelbine The risk or severity of bleeding can be increased when Lepirudin is combined with Vinorelbine. DB00380 Dexrazoxane The risk or severity of bleeding can be increased when Lepirudin is combined with Dexrazoxane. DB00398 Sorafenib The risk or severity of bleeding can be increased when Lepirudin is combined with Sorafenib. DB00428 Streptozocin The risk or severity of bleeding can be increased when Lepirudin is combined with Streptozocin. DB00441 Gemcitabine The risk or severity of bleeding can be increased when Lepirudin is combined with Gemcitabine. DB00444 Teniposide The risk or severity of bleeding can be increased when Lepirudin is combined with Teniposide. DB00445 Epirubicin The risk or severity of bleeding can be increased when Lepirudin is combined with Epirubicin. DB00446 Chloramphenicol The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol. DB00480 Lenalidomide The risk or severity of bleeding can be increased when Lepirudin is combined with Lenalidomide. DB00488 Altretamine The risk or severity of bleeding can be increased when Lepirudin is combined with Altretamine. DB00495 Zidovudine The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine. DB00515 Cisplatin The risk or severity of bleeding can be increased when Lepirudin is combined with Cisplatin. DB00526 Oxaliplatin The risk or severity of bleeding can be increased when Lepirudin is combined with Oxaliplatin. DB00531 Cyclophosphamide The risk or severity of bleeding can be increased when Lepirudin is combined with Cyclophosphamide. DB00544 Fluorouracil The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil. DB00552 Pentostatin The risk or severity of bleeding can be increased when Lepirudin is combined with Pentostatin. DB00563 Methotrexate The risk or severity of bleeding can be increased when Lepirudin is combined with Methotrexate. DB00564 Carbamazepine The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine. DB00570 Vinblastine The risk or severity of bleeding can be increased when Lepirudin is combined with Vinblastine. DB00619 Imatinib The risk or severity of bleeding can be increased when Lepirudin is combined with Imatinib. DB00631 Clofarabine The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine. DB00642 Pemetrexed The risk or severity of bleeding can be increased when Lepirudin is combined with Pemetrexed. DB00694 Daunorubicin The risk or severity of bleeding can be increased when Lepirudin is combined with Daunorubicin. DB00762 Irinotecan The risk or severity of bleeding can be increased when Lepirudin is combined with Irinotecan. DB00773 Etoposide The risk or severity of bleeding can be increased when Lepirudin is combined with Etoposide. DB00851 Dacarbazine The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine. DB00853 Temozolomide The risk or severity of bleeding can be increased when Lepirudin is combined with Temozolomide. DB00859 Penicillamine The risk or severity of bleeding can be increased when Lepirudin is combined with Penicillamine. DB00864 Tacrolimus The risk or severity of bleeding can be increased when Lepirudin is combined with Tacrolimus. DB00877 Sirolimus The risk or severity of bleeding can be increased when Lepirudin is combined with Sirolimus. DB00888 Mechlorethamine The risk or severity of bleeding can be increased when Lepirudin is combined with Mechlorethamine. DB00928 Azacitidine The risk or severity of bleeding can be increased when Lepirudin is combined with Azacitidine. DB00958 Carboplatin The risk or severity of bleeding can be increased when Lepirudin is combined with Carboplatin. DB00970 Dactinomycin The risk or severity of bleeding can be increased when Lepirudin is combined with Dactinomycin. DB00987 Cytarabine The risk or severity of bleeding can be increased when Lepirudin is combined with Cytarabine. DB00997 Doxorubicin The risk or severity of bleeding can be increased when Lepirudin is combined with Doxorubicin. DB01005 Hydroxyurea The risk or severity of bleeding can be increased when Lepirudin is combined with Hydroxyurea. DB01008 Busulfan The risk or severity of bleeding can be increased when Lepirudin is combined with Busulfan. DB01030 Topotecan The risk or severity of bleeding can be increased when Lepirudin is combined with Topotecan. DB01033 Mercaptopurine The risk or severity of bleeding can be increased when Lepirudin is combined with Mercaptopurine. DB01041 Thalidomide The risk or severity of bleeding can be increased when Lepirudin is combined with Thalidomide. DB01042 Melphalan The risk or severity of bleeding can be increased when Lepirudin is combined with Melphalan. DB01073 Fludarabine The risk or severity of bleeding can be increased when Lepirudin is combined with Fludarabine. DB01099 Flucytosine The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine. DB01101 Capecitabine The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine. DB01169 Arsenic trioxide The risk or severity of bleeding can be increased when Lepirudin is combined with Arsenic trioxide. DB01177 Idarubicin The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin. DB01204 Mitoxantrone The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone. DB01206 Lomustine The risk or severity of bleeding can be increased when Lepirudin is combined with Lomustine. DB01229 Paclitaxel The risk or severity of bleeding can be increased when Lepirudin is combined with Paclitaxel. DB01248 Docetaxel The risk or severity of bleeding can be increased when Lepirudin is combined with Docetaxel. DB01262 Decitabine The risk or severity of bleeding can be increased when Lepirudin is combined with Decitabine. DB01280 Nelarabine The risk or severity of bleeding can be increased when Lepirudin is combined with Nelarabine. DB01590 Everolimus The risk or severity of bleeding can be increased when Lepirudin is combined with Everolimus. DB02546 Vorinostat The risk or severity of bleeding can be increased when Lepirudin is combined with Vorinostat. DB04572 Thiotepa The risk or severity of bleeding can be increased when Lepirudin is combined with Thiotepa. DB04845 Ixabepilone The risk or severity of bleeding can be increased when Lepirudin is combined with Ixabepilone. DB04868 Nilotinib The risk or severity of bleeding can be increased when Lepirudin is combined with Nilotinib. DB05015 Belinostat The risk or severity of bleeding can be increased when Lepirudin is combined with Belinostat. DB05109 Trabectedin The risk or severity of bleeding can be increased when Lepirudin is combined with Trabectedin. DB05258 Interferon alfa The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa. DB05472 Human interferon omega-1 The risk or severity of bleeding can be increased when Lepirudin is combined with Human interferon omega-1. DB05773 Trastuzumab emtansine The risk or severity of bleeding can be increased when Lepirudin is combined with Trastuzumab emtansine. DB06287 Temsirolimus The risk or severity of bleeding can be increased when Lepirudin is combined with Temsirolimus. DB06616 Bosutinib The risk or severity of bleeding can be increased when Lepirudin is combined with Bosutinib. DB06769 Bendamustine The risk or severity of bleeding can be increased when Lepirudin is combined with Bendamustine. DB06772 Cabazitaxel The risk or severity of bleeding can be increased when Lepirudin is combined with Cabazitaxel. DB08871 Eribulin The risk or severity of bleeding can be increased when Lepirudin is combined with Eribulin. DB08877 Ruxolitinib The risk or severity of bleeding can be increased when Lepirudin is combined with Ruxolitinib. DB08889 Carfilzomib The risk or severity of bleeding can be increased when Lepirudin is combined with Carfilzomib. DB08895 Tofacitinib The risk or severity of bleeding can be increased when Lepirudin is combined with Tofacitinib. DB08901 Ponatinib The risk or severity of bleeding can be increased when Lepirudin is combined with Ponatinib. DB08910 Pomalidomide The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide. DB09042 Tedizolid phosphate The risk or severity of bleeding can be increased when Lepirudin is combined with Tedizolid phosphate. DB09052 Blinatumomab The risk or severity of bleeding can be increased when Lepirudin is combined with Blinatumomab. DB09073 Palbociclib The risk or severity of bleeding can be increased when Lepirudin is combined with Palbociclib. DB09074 Olaparib The risk or severity of bleeding can be increased when Lepirudin is combined with Olaparib. DB09077 Dinutuximab The risk or severity of bleeding can be increased when Lepirudin is combined with Dinutuximab. DB09122 Peginterferon beta-1a The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon beta-1a. DB12814 Cepeginterferon alfa-2B The risk or severity of bleeding can be increased when Lepirudin is combined with Cepeginterferon alfa-2B. DB00229 Cefotiam The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotiam. DB00267 Cefmenoxime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmenoxime. DB00274 Cefmetazole The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmetazole. DB00430 Cefpiramide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpiramide. DB00438 Ceftazidime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftazidime. DB00447 Loracarbef The therapeutic efficacy of Lepirudin can be decreased when used in combination with Loracarbef. DB00456 Cefalotin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefalotin. DB00493 Cefotaxime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotaxime. DB00535 Cefdinir The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefdinir. DB00567 Cephalexin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin. DB00671 Cefixime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime. DB00689 Cephaloglycin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephaloglycin. DB00833 Cefaclor The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaclor. DB00923 Ceforanide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceforanide. DB01066 Cefditoren The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefditoren. DB01112 Cefuroxime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefuroxime. DB01139 Cefapirin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefapirin. DB01140 Cefadroxil The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefadroxil. DB01150 Cefprozil The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefprozil. DB01212 Ceftriaxone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftriaxone. DB01326 Cefamandole The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole. DB01327 Cefazolin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazolin. DB01328 Cefonicid The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefonicid. DB01329 Cefoperazone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoperazone. DB01330 Cefotetan The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan. DB01331 Cefoxitin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoxitin. DB01332 Ceftizoxime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftizoxime. DB01333 Cefradine The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefradine. DB01413 Cefepime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefepime. DB01414 Cefacetrile The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefacetrile. DB01415 Ceftibuten The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftibuten. DB01416 Cefpodoxime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpodoxime. DB04570 Latamoxef The therapeutic efficacy of Lepirudin can be decreased when used in combination with Latamoxef. DB04918 Ceftobiprole The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole. DB06590 Ceftaroline fosamil The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftaroline fosamil. DB09008 Cefaloridine The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaloridine. DB09050 Ceftolozane The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftolozane. DB09062 Cefminox The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefminox. DB11367 Cefroxadine The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefroxadine. DB11935 Flomoxef The therapeutic efficacy of Lepirudin can be decreased when used in combination with Flomoxef. DB13266 Cefatrizine The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefatrizine. DB13461 Cefcapene The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefcapene. DB13470 Cefodizime The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefodizime. DB13499 Cefsulodin The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefsulodin. DB13504 Cefetamet The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefetamet. DB13638 Cefbuperazone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefbuperazone. DB13667 Cefozopran The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefozopran. DB13682 Cefpirome The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpirome. DB13778 Cefazedone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazedone. DB13821 Ceftezole The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftezole. DB14725 Cefamandole nafate The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole nafate. DB00254 Doxycycline The risk or severity of bleeding can be increased when Doxycycline is combined with Lepirudin. DB00207 Azithromycin The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin. DB09539 Omega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Lepirudin. DB00945 Acetylsalicylic acid Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin. DB01606 Tazobactam The risk or severity of bleeding can be increased when Tazobactam is combined with Lepirudin. DB00199 Erythromycin The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin. DB00656 Trazodone The risk or severity of bleeding can be increased when Trazodone is combined with Lepirudin. DB00620 Triamcinolone The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triamcinolone. DB09079 Nintedanib The risk or severity of bleeding can be increased when Nintedanib is combined with Lepirudin. DB01175 Escitalopram The risk or severity of bleeding can be increased when Escitalopram is combined with Lepirudin. DB01104 Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Lepirudin. DB00232 Methyclothiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methyclothiazide. DB00436 Bendroflumethiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Bendroflumethiazide. DB00562 Benzthiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Benzthiazide. DB00606 Cyclothiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclothiazide. DB00774 Hydroflumethiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroflumethiazide. DB00880 Chlorothiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Chlorothiazide. DB00999 Hydrochlorothiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydrochlorothiazide. DB01021 Trichlormethiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trichlormethiazide. DB01324 Polythiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Polythiazide. DB13430 Mebutizide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mebutizide. DB13532 Cyclopenthiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclopenthiazide. DB15861 Buthiazide The therapeutic efficacy of Lepirudin can be decreased when used in combination with Buthiazide. DB00783 Estradiol The risk or severity of adverse effects can be increased when Estradiol is combined with Lepirudin. DB00977 Ethinylestradiol The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Lepirudin. DB00834 Mifepristone The risk or severity of adverse effects can be increased when Mifepristone is combined with Lepirudin. DB13310 Ormeloxifene The risk or severity of adverse effects can be increased when Ormeloxifene is combined with Lepirudin. DB00304 Desogestrel The risk or severity of adverse effects can be increased when Desogestrel is combined with Lepirudin. DB00351 Megestrol acetate The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Lepirudin. DB00367 Levonorgestrel The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Lepirudin. DB00603 Medroxyprogesterone acetate The risk or severity of adverse effects can be increased when Medroxyprogesterone acetate is combined with Lepirudin. DB00717 Norethisterone The risk or severity of adverse effects can be increased when Norethisterone is combined with Lepirudin. DB00823 Ethynodiol diacetate The risk or severity of adverse effects can be increased when Ethynodiol diacetate is combined with Lepirudin. DB00957 Norgestimate The risk or severity of adverse effects can be increased when Norgestimate is combined with Lepirudin. DB01395 Drospirenone The risk or severity of adverse effects can be increased when Drospirenone is combined with Lepirudin. DB04839 Cyproterone acetate The risk or severity of adverse effects can be increased when Cyproterone acetate is combined with Lepirudin. DB06730 Gestodene The risk or severity of adverse effects can be increased when Gestodene is combined with Lepirudin. DB09123 Dienogest The risk or severity of adverse effects can be increased when Dienogest is combined with Lepirudin. DB09371 Norethynodrel The risk or severity of adverse effects can be increased when Norethynodrel is combined with Lepirudin. DB09389 Norgestrel The risk or severity of adverse effects can be increased when Norgestrel is combined with Lepirudin. DB11619 Gestrinone The risk or severity of adverse effects can be increased when Gestrinone is combined with Lepirudin. DB12474 Lynestrenol The risk or severity of adverse effects can be increased when Lynestrenol is combined with Lepirudin. DB13528 Chlormadinone The risk or severity of adverse effects can be increased when Chlormadinone is combined with Lepirudin. DB13563 Norgestrienone The risk or severity of adverse effects can be increased when Norgestrienone is combined with Lepirudin. DB13685 Quingestanol The risk or severity of adverse effects can be increased when Quingestanol is combined with Lepirudin. DB13857 Demegestone The risk or severity of adverse effects can be increased when Demegestone is combined with Lepirudin. DB13981 Nomegestrol acetate The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Lepirudin. DB14678 Norethindrone enanthate The risk or severity of adverse effects can be increased when Norethindrone enanthate is combined with Lepirudin. DB15775 Algestone acetophenide The risk or severity of adverse effects can be increased when Algestone acetophenide is combined with Lepirudin. DB15903 Chlormadinone acetate The risk or severity of adverse effects can be increased when Chlormadinone acetate is combined with Lepirudin. DB12235 Estetrol The risk or severity of adverse effects can be increased when Estetrol is combined with Lepirudin. DB11201 Menthyl salicylate The risk or severity of bleeding and hemorrhage can be increased when Menthyl salicylate is combined with Lepirudin. DB11323 Glycol salicylate The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Lepirudin. DB15119 Ropeginterferon alfa-2b The risk or severity of bleeding can be increased when Lepirudin is combined with Ropeginterferon alfa-2b. >DB00001 sequence LVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIP EEYLQ Melting Point 65 °C Otto, A. & Seckler, R. Eur. J. Biochem. 202:67-73 (1991) Hydrophobicity -0.777 Isoelectric Point 4.04 Molecular Weight 6963.425 Molecular Formula C287H440N80O110S6 Drugs Product Database (DPD) 11916 PubChem Substance 46507011 KEGG Drug D06880 PharmGKB PA450195 UniProtKB P01050 Therapeutic Targets Database DAP000541 Wikipedia Lepirudin ChEMBL CHEMBL1201666 RxCUI 237057 RxList http://www.rxlist.com/cgi/generic/lepirudin.htm Drugs.com http://www.drugs.com/cdi/lepirudin.html SMP0000278 Lepirudin Action Pathway drug_action DB00001 Lepirudin DB01022 Phylloquinone DB01373 Calcium P00734 P00748 P02452 P03952 P03951 P00740 P00451 P12259 P00742 P02671 P02675 P02679 P00488 P05160 P00747 P00750 P08709 P13726 Q9BQB6 P38435 BE0000048 Prothrombin Humans inhibitor
A1703 10505536 Turpie AG: Anticoagulants in acute coronary syndromes. Am J Cardiol. 1999 Sep 2;84(5A):2M-6M.
A1705 10912644 Warkentin TE: Venous thromboembolism in heparin-induced thrombocytopenia. Curr Opin Pulm Med. 2000 Jul;6(4):343-51.
A1707 11055889 Eriksson BI: New therapeutic options in deep vein thrombosis prophylaxis. Semin Hematol. 2000 Jul;37(3 Suppl 5):7-9.
A1709 11467439 Fabrizio MC: Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass. J Extra Corpor Technol. 2001 May;33(2):117-25.
A1711 11807012 Szaba FM, Smiley ST: Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood. 2002 Feb 1;99(3):1053-9.
A9 11752352 Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
yes Prothrombin Thrombospondin receptor activity Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. F2 11p11-q12 Secreted 1-24 5.7 70036.295 11 Humans HUGO Gene Nomenclature Committee (HGNC) HGNC:3535 GenAtlas F2 GenBank Gene Database M17262 GenBank Protein Database 339641 Guide to Pharmacology 2362 UniProtKB P00734 UniProt Accession THRB_HUMAN 3.4.21.5 Coagulation factor II >lcl|BSEQ0016004|Prothrombin MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLEREC VEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHV NITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQE CSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASA QAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETG DGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYI DGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST RIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKY GFYTHVFRLKKWIQKVIDQFGE >lcl|BSEQ0016005|Prothrombin (F2) ATGGCGCACGTCCGAGGCTTGCAGCTGCCTGGCTGCCTGGCCCTGGCTGCCCTGTGTAGC CTTGTGCACAGCCAGCATGTGTTCCTGGCTCCTCAGCAAGCACGGTCGCTGCTCCAGCGG GTCCGGCGAGCCAACACCTTCTTGGAGGAGGTGCGCAAGGGCAACCTGGAGCGAGAGTGC GTGGAGGAGACGTGCAGCTACGAGGAGGCCTTCGAGGCTCTGGAGTCCTCCACGGCTACG GATGTGTTCTGGGCCAAGTACACAGCTTGTGAGACAGCGAGGACGCCTCGAGATAAGCTT GCTGCATGTCTGGAAGGTAACTGTGCTGAGGGTCTGGGTACGAACTACCGAGGGCATGTG AACATCACCCGGTCAGGCATTGAGTGCCAGCTATGGAGGAGTCGCTACCCACATAAGCCT GAAATCAACTCCACTACCCATCCTGGGGCCGACCTACAGGAGAATTTCTGCCGCAACCCC GACAGCAGCACCACGGGACCCTGGTGCTACACTACAGACCCCACCGTGAGGAGGCAGGAA TGCAGCATCCCTGTCTGTGGCCAGGATCAAGTCACTGTAGCGATGACTCCACGCTCCGAA GGCTCCAGTGTGAATCTGTCACCTCCATTGGAGCAGTGTGTCCCTGATCGGGGGCAGCAG TACCAGGGGCGCCTGGCGGTGACCACACATGGGCTCCCCTGCCTGGCCTGGGCCAGCGCA CAGGCCAAGGCCCTGAGCAAGCACCAGGACTTCAACTCAGCTGTGCAGCTGGTGGAGAAC TTCTGCCGCAACCCAGACGGGGATGAGGAGGGCGTGTGGTGCTATGTGGCCGGGAAGCCT GGCGACTTTGGGTACTGCGACCTCAACTATTGTGAGGAGGCCGTGGAGGAGGAGACAGGA GATGGGCTGGATGAGGACTCAGACAGGGCCATCGAAGGGCGTACCGCCACCAGTGAGTAC CAGACTTTCTTCAATCCGAGGACCTTTGGCTCGGGAGAGGCAGACTGTGGGCTGCGACCT CTGTTCGAGAAGAAGTCGCTGGAGGACAAAACCGAAAGAGAGCTCCTGGAATCCTACATC GACGGGCGCATTGTGGAGGGCTCGGATGCAGAGATCGGCATGTCACCTTGGCAGGTGATG CTTTTCCGGAAGAGTCCCCAGGAGCTGCTGTGTGGGGCCAGCCTCATCAGTGACCGCTGG GTCCTCACCGCCGCCCACTGCCTCCTGTACCCGCCCTGGGACAAGAACTTCACCGAGAAT GACCTTCTGGTGCGCATTGGCAAGCACTCCCGCACCAGGTACGAGCGAAACATTGAAAAG ATATCCATGTTGGAAAAGATCTACATCCACCCCAGGTACAACTGGCGGGAGAACCTGGAC CGGGACATTGCCCTGATGAAGCTGAAGAAGCCTGTTGCCTTCAGTGACTACATTCACCCT GTGTGTCTGCCCGACAGGGAGACGGCAGCCAGCTTGCTCCAGGCTGGATACAAGGGGCGG GTGACAGGCTGGGGCAACCTGAAGGAGACGTGGACAGCCAACGTTGGTAAGGGGCAGCCC AGTGTCCTGCAGGTGGTGAACCTGCCCATTGTGGAGCGGCCGGTCTGCAAGGACTCCACC CGGATCCGCATCACTGACAACATGTTCTGTGCTGGTTACAAGCCTGATGAAGGGAAACGA GGGGATGCCTGTGAAGGTGACAGTGGGGGACCCTTTGTCATGAAGAGCCCCTTTAACAAC CGCTGGTATCAAATGGGCATCGTCTCATGGGGTGAAGGCTGTGACCGGGATGGGAAATAT GGCTTCTACACACATGTGTTCCGCCTGAAGAAGTGGATACAGAAGGTCATTGATCAGTTT GGAGAGTAG PF00594 Gla PF00051 Kringle PF00089 Trypsin PF09396 Thrombin_light component blood microparticle component cytosol component endoplasmic reticulum lumen component extracellular exosome component extracellular matrix component extracellular region component extracellular space component Golgi lumen component plasma membrane function calcium ion binding function growth factor activity function receptor binding function serine-type endopeptidase activity function thrombospondin receptor activity process acute-phase response process blood coagulation process blood coagulation, intrinsic pathway process cell surface receptor signaling pathway process cellular protein metabolic process process cellular response to mechanical stimulus process cytosolic calcium ion homeostasis process fibrinolysis process leukocyte migration process multicellular organismal development process negative regulation of astrocyte differentiation process negative regulation of fibrinolysis process negative regulation of platelet activation process negative regulation of proteolysis process peptidyl-glutamic acid carboxylation process platelet activation process positive regulation of blood coagulation process positive regulation of cell growth process positive regulation of cell proliferation process positive regulation of collagen biosynthetic process process positive regulation of phosphatidylinositol 3-kinase signaling process positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway process positive regulation of protein phosphorylation process positive regulation of reactive oxygen species metabolic process process positive regulation of release of sequestered calcium ion into cytosol process post-translational protein modification process proteolysis process regulation of blood coagulation process regulation of cell shape process regulation of gene expression process response to inactivity process response to wounding

你可能感兴趣的:(知识图谱,药物互作,数据集,药物互作)